45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
3,050
Insurances with rates
77
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| RX-137245 | NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION | $455,356 | $455,356 | — | — | 120 |
| RX-202017 | TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION | $107,550 | $107,550 | — | — | 120 |
| RX-127653 | ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION | $89,233 | $89,233 | — | — | 120 |
| RX-199684 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $87,089 | $87,089 | — | — | 120 |
| RX-137896 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $65,143 | $65,143 | — | — | 37 |
| RX-190594 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $59,184 | $59,184 | — | — | 120 |
| RX-207058 | ROZANOLIXIZUMAB-NOLI 140 MG/ML SUBCUTANEOUS SOLUTION | $56,797 | $56,797 | — | — | 120 |
| RX-208617 | TORIPALIMAB-TPZI 240 MG/6 ML (40 MG/ML) INTRAVENOUS SOLUTION | $48,786 | $48,786 | — | — | 106 |
| RX-210073 | TARLATAMAB-DLLE 10 MG INTRAVENOUS SOLUTION | $46,350 | $46,350 | — | — | 117 |
| PX-36137225003 | HC Revascularization Endovascular Open/Perc Femoral/Popliteal Artery W/Atherectomy Bl | $45,523 | $29,590 | — | — | 39 |
| RX-206087 | RETIFANLIMAB-DLWR 500 MG/20 ML INTRAVENOUS SOLUTION | $45,114 | $45,114 | — | — | 120 |
| RX-105644 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $44,160 | $44,160 | — | — | 120 |
| RX-196883 | PERTUZUMAB 1,200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN | $43,628 | $43,628 | — | — | 120 |
| RX-207693 | ELRANATAMAB-BCMM 40 MG/ML SUBCUTANEOUS SOLUTION | $42,858 | $42,858 | — | — | 117 |
| PX-481C9600001 | HC Placement Percutaneous Drug Eluting Stent Intracoronary W/Angiography 1 Artery/Branch | $41,495 | $26,972 | — | — | 118 |
| RX-110751 | LEUPROLIDE ACETATE (6 MONTH) 45 MG INTRAMUSCULAR SYRINGE KIT | $37,312 | $37,312 | — | — | 120 |
| PX-481C9606001 | HC Revascularization Acute/Total/Subtotal to Ami/Drug Eluting Coronary Stent Percutaneous Single | $36,762 | $23,895 | — | — | 32 |
| RX-207664 | TALQUETAMAB-TGVS 40 MG/ML SUBCUTANEOUS SOLUTION | $35,942 | $35,942 | — | — | 117 |
| RX-188251 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $34,004 | $34,004 | — | — | 120 |
| RX-196290 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $33,714 | $33,714 | — | — | 37 |
| PX-36133285001 | HC Insertion Subcutaneous Cardiac Rhythm Monitor | $30,884 | $20,075 | — | — | 118 |
| PX-36137225001 | HC Revascularization Endovascular Open/Perc Femoral/Popliteal Artery W/Atherectomy Lt | $30,348 | $19,726 | — | — | 39 |
| PX-36137225002 | HC Revascularization Endovascular Open/Perc Femoral/Popliteal Artery W/Atherectomy Rt | $30,348 | $19,726 | — | — | 39 |
| RX-203310 | RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION | $30,072 | $30,072 | — | — | 120 |
| RX-124767 | OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION | $28,351 | $28,351 | — | — | 120 |
| PX-36136482002 | HC Ablation Extremity Percutaneous Transcatheter Delivery 1st Vein Treated Bl | $27,386 | $17,801 | — | — | 118 |
| PX-36133228001 | HC Removal/Replacement Ppm Generator Dual Lead System | $25,857 | $16,807 | — | — | 118 |
| RX-196642 | LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION | $25,230 | $25,230 | — | — | 120 |
| PX-36000000026 | HC or Level VI Initial 15 Minutes | $23,746 | $15,435 | — | — | 32 |
| RX-164818 | TENECTEPLASE 50 MG INTRAVENOUS SOLUTION | $23,582 | $23,582 | — | — | 106 |
| RX-215376 | TENECTEPLASE 25 MG INTRAVENOUS SOLUTION | $23,582 | $23,582 | — | — | 106 |
| PX-36137211001 | HC Infusion Transcatheter Arterial Thrombolysis Not Coronary/Intracranial Initial Treatment Day Bl | $22,868 | $14,864 | — | — | 118 |
| RX-139635 | RITUXIMAB 1,600 MG/13.4 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN | $22,548 | $22,548 | — | — | 120 |
| PX-36133208001 | HC Insertion of New/Replacement Ppm W/Transvenous Electrode(S) Atrial & Ventricular | $22,403 | $14,562 | — | — | 118 |
| RX-201101 | TISOTUMAB VEDOTIN-TFTV 40 MG INTRAVENOUS SOLUTION | $22,202 | $22,202 | — | — | 120 |
| PX-36000000025 | HC or Level V Initial 15 Minutes | $21,714 | $14,114 | — | — | 32 |
| RX-116596 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION | $20,666 | $20,666 | — | — | 120 |
| RX-204870 | MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION | $20,601 | $20,601 | — | — | 120 |
| RX-190585 | MEPOLIZUMAB 100 MG/ML SUBCUTANEOUS AUTO-INJECTOR | $19,955 | $19,955 | — | — | 37 |
| RX-139634 | RITUXIMAB 1,400 MG/11.7 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN | $19,730 | $19,730 | — | — | 120 |
| RX-188418 | PEGFILGRASTIM-CBQV 6 MG/0.6 ML SUBCUTANEOUS SYRINGE | $19,201 | $19,201 | — | — | 120 |
| PX-361C9764003 | HC Revascularization Endovascular Open/Perc Lower Extremity Art Excpt T/P W/Intravasc Lithotripsy Rt | $18,785 | $12,210 | — | — | 115 |
| PX-361C9764004 | HC Revascularization Endovascular Open/Perc Lower Extremity Art Excpt T/P W/Intravasc Lithotripsy | $18,785 | $12,210 | — | — | 115 |
| PX-361C9764002 | HC Revascularization Endovascular Open/Perc Lower Extremity Art Excpt T/P W/Intravasc Lithotripsy Lt | $18,785 | $12,210 | — | — | 115 |
| RX-21045 | LEUPROLIDE ACETATE 22.5 MG (3 MONTH) INTRAMUSCULAR SYRINGE KIT | $18,656 | $18,656 | — | — | 120 |
| RX-129782 | DARBEPOETIN ALFA 500 MCG/ML IN POLYSORBATE INJECTION SYRINGE | $18,649 | $18,649 | — | — | 120 |
| PX-36136482001 | HC Ablation Extremity Percutaneous Transcatheter Delivery 1st Vein Treated | $18,257 | $11,867 | — | — | 118 |
| PX-36136482004 | HC Ablation Extremity Percutaneous Transcatheter Delivery 1st Vein Treated Rt | $18,257 | $11,867 | — | — | 118 |
| PX-36136482003 | HC Ablation Extremity Percutaneous Transcatheter Delivery 1st Vein Treated Lt | $18,257 | $11,867 | — | — | 118 |
| RX-129657 | PEGFILGRASTIM 6 MG/0.6 ML SUBCUTANEOUS SYRINGE | $17,710 | $17,710 | — | — | 120 |
Showing top 50 of 3,050 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.